TEMODAR® contains a medicine called temozolomide. This medicine is an antitumour agent for the treatment of specific forms of brain tumours. TEMODAR® belongs to a group of medicines called cytotoxic or chemotherapy medicines. Therapeutic group: Antineoplastic preparation.
TEMODAR® capsules are indicated for the treatment of:
1. Adult patients suffering from newly diagnosed glioblastoma multiforme in a combination treatment with radiation and subsequently as monotherapy treatment;
2. Children above the age of 3 years, adolescents and adults suffering from malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma (specific forms of brain tumours), showing recurrence or progression after standard therapy;
3. TEMODAR® capsules are also indicated as first line treatment for adult patients with advanced metastatic malignant melanoma.
